|
Sep 2026
As of Sep 30, 2026
|
Jun 2026
As of Jun 30, 2026
|
Mar 2026
As of Mar 31, 2026
|
|
|---|---|---|---|
| Assets | |||
| Current assets: | |||
| Cash and cash equivalents | |||
| Marketable securities | |||
| Prepaid expenses and other current assets | |||
| Total current assets | |||
| Property and equipment, net | |||
| Restricted cash | |||
| Long-term marketable securities | |||
| Non-current clinical deposits | |||
| Operating lease right-of-use assets | |||
| Other non-current assets | |||
| Total assets | |||
| Liabilities, convertible preferred stock and stockholders' equity (deficit) | |||
| Current liabilities: | |||
| Accounts payable | |||
| Accrued expenses and other current liabilities | |||
| Operating lease liabilities, current | |||
| Total current liabilities | |||
| Operating lease liabilities, non-current | |||
| Other non-current liabilities | |||
| Total liabilities | |||
| Convertible preferred stock | |||
| Series A Convertible Preferred Stock | |||
| Series B Convertible Preferred Stock | |||
| Total convertible preferred stock | |||
| Stockholders' equity (deficit): | |||
| Preferred stock | |||
| Common stock | |||
| Additional paid-in capital | |||
| Accumulated other comprehensive (loss) income | |||
| Accumulated deficit | |||
| Total stockholders' equity (deficit) | |||
| Total liabilities, convertible preferred stock and stockholders' equity (deficit) |
Loading...